Inventor · disambiguated record
Darrin Anthony Lindhout
Also filed as: LINDHOUT DARRIN A · LINDHOUT DARRIN ANTHONY
27 granted patents·13 pending applications·443 citations·filing 2012–2023
97Inventor score
Top patents by PatentIndex Score
40 records- 0198US9751924B2Methods of using compositions comprising fusion variants of FGF19 polypeptides for reducing glucose levels in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Sep 5, 2017·32 cites·113 claims
- 0298US9670260B2Compositions comprising fusion variants of FGF19 polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·34 cites·28 claims
- 0398US9580483B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of diabetesNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Feb 28, 2017·36 cites·120 claims
- 0498US9089525B1Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Jul 28, 2015·37 cites·91 claims
- 0597US9290557B2Compositions comprising variants and fusions of FGF19 polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2013·Granted Mar 22, 2016·37 cites·63 claims
- 0697US9161966B2GDF15 mutein polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2014·Granted Oct 20, 2015·29 cites·25 claims
- 0796US9963494B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2013·Granted May 8, 2018·19 cites·85 claims
- 0896US9827291B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·16 cites·46 claims
- 0995US10398758B2Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditionsNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Sep 3, 2019·9 cites·32 claims
- 1095US9920118B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Mar 20, 2018·19 cites·34 claims
- 1195US8951966B2Compositions comprising variants and fusions of FGF19 polypeptides, and uses and methods thereof for treatment of metabolic disorders and diseasesLING LEI·Filed 2012·Granted Feb 10, 2015·61 cites·46 claims
- 1294US10413590B2Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Sep 17, 2019·10 cites·121 claims
- 1394US9834586B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·18 cites·61 claims
- 1494US9550819B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2013·Granted Jan 24, 2017·22 cites·33 claims
- 1593US10195250B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2016·Granted Feb 5, 2019·12 cites·34 claims
- 1692US10869909B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Dec 22, 2020·4 cites·34 claims
- 1792US10610568B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2020·5 cites·37 claims
- 1892US9828415B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2014·Granted Nov 28, 2017·17 cites·46 claims
- 1991US10517929B2Pharmaceutical compositions comprising FGF19 variantsNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Dec 31, 2019·9 cites·82 claims
- 2090US11358995B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Jun 14, 2022·2 cites·33 claims
- 2190US10323075B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 18, 2019·8 cites·34 claims
- 2289US11530260B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·2 cites·44 claims
- 2388US10562965B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Feb 18, 2020·5 cites·39 claims
- 2488US2024050530A1Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Metabolic Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2582US12173060B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 2678US2022088140A1Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Metabolic Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2776US11065302B2Compositions comprising fusion variants of FGF19 polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·0 cites·12 claims
- 2870US2021388047A1Compositions and Methods of Use for Treating Metabolic DisordersNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2969US2022047675A1Pharmaceutical compositions comprising peptide variants and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3067US11066454B2Compositions comprising variants and fusions of FGF19 polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·0 cites·10 claims
- 3167US10758590B2Methods of using compositions comprising variants and fusions of FGF 19 polypeptides for treating diabetesNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Sep 1, 2020·0 cites·38 claims
- 3267US2020197490A1Pharmaceutical compositions comprising peptide variants and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3366US2021169983A1Compositions and Methods for Treatment of Metabolic Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3461US2020087366A1Compositions and Methods of Use For Treating Metabolic DisordersNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3559US2016200788A1Compositions, uses and methods for treatment of metabolic disorders and diseasesNGM BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3659US2020054714A1Methods and Compositions for the Treatment of Metabolic Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3753US2018134761A1Compositions and Methods of Use for Treating Metabolic DisordersNGM BIOPHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3850US2024279360A1Bifunctional compounds containing igf-2 polypeptidesLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3947US2023279426A1Modified viral compositions for viral transductionLYCIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4043US2023226214A1Bifunctional bridging compositions for viral transductionLYCIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Darrin Anthony Lindhout files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →